TBM Blog Early Data Shows COVID-19 Vaccine Is 90% Effective

Drugmaker Pfizer Inc. announced in a press release that early data from its COVID-19 vaccine trial indicates that the vaccine candidate has demonstrated high efficacy. The Phase 3 vaccine candidate's early results were found in an interim analysis by an independent data monitoring board to be more than 90% effective in preventing COVID-19 in participants ...Early Data Shows COVID-19 Vaccine Is 90% Effective Read More »The post Early Data Shows COVID-19 Vaccine Is 90% Effective appeared first on Tanner Ballew & Maloof.